tiprankstipranks
Trending News
More News >
CSPC Pharmaceutical Group Limited (CHJTF)
OTHER OTC:CHJTF
US Market

CSPC Pharmaceutical Group (CHJTF) Stock Forecast & Price Target

Compare
22 Followers
See the Price Targets and Ratings of:

CHJTF Analyst Ratings

Moderate Buy
8Ratings
Moderate Buy
5 Buy
2 Hold
1 Sell
Based on 8 analysts giving stock ratings to
CSPC
Pharmaceutical Group
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CHJTF Stock 12 Month Forecast

Average Price Target

$0.97
▼(-2.02%Downside)
Based on 8 Wall Street analysts offering 12 month price targets for CSPC Pharmaceutical Group in the last 3 months. The average price target is $0.97 with a high forecast of $1.30 and a low forecast of $0.64. The average price target represents a -2.02% change from the last price of $0.99.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","-1":"-$1","-0.25":"-$0.25","0.5":"$0.5","1.25":"$1.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1.30198712,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.30</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.97,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$0.97</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.63698,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$0.64</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,-0.25,0.5,1.25,2],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2024","6":"Nov<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.85,0.88476824,0.91953648,0.95430472,0.98907296,1.0238412,1.05860944,1.09337768,1.12814592,1.16291416,1.1976824,1.23245064,1.26721888,{"y":1.30198712,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.85,0.8592307692307692,0.8684615384615384,0.8776923076923077,0.8869230769230769,0.8961538461538461,0.9053846153846153,0.9146153846153846,0.9238461538461538,0.933076923076923,0.9423076923076923,0.9515384615384614,0.9607692307692307,{"y":0.97,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.85,0.8336138461538461,0.8172276923076923,0.8008415384615384,0.7844553846153846,0.7680692307692307,0.7516830769230769,0.7352969230769231,0.7189107692307692,0.7025246153846154,0.6861384615384616,0.6697523076923076,0.6533661538461538,{"y":0.63698,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.71,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.73,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.78,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.76,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.7,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.75,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.67,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.6,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.57,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.59,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.55,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.63,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.85,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$1.30Average Price Target$0.97Lowest Price Target$0.64
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on CHJTF
Rebecca LiangBernstein
Bernstein
$0.64
Hold
-35.65%
Downside
Reiterated
06/24/25
Bernstein Sticks to Its Hold Rating for CSPC Pharmaceutical Group (CHJTF)
Nomura
$1.02$1.3
Buy
31.52%
Upside
Reiterated
06/16/25
Nomura Sticks to Their Buy Rating for CSPC Pharmaceutical Group (CHJTF)
HSBC
$0.6$1.21
Buy
22.26%
Upside
Upgraded
06/05/25
Positive Report for CSPC Pharmaceutical Group (CHJTF) from HSBC
CMB International Securities Analyst forecast on CHJTF
Jill WuCMB International Securities
CMB International Securities
$0.73$1.28
Buy
29.72%
Upside
Reiterated
06/02/25
Analysts Are Bullish on These Healthcare Stocks: Kymera Therapeutics (KYMR), CSPC Pharmaceutical Group (CHJTF)
Jefferies Analyst forecast on CHJTF
Chu WangJefferies
Jefferies
$0.64
Sell
-35.65%
Downside
Downgraded
06/01/25
Analysts Conflicted on These Healthcare Names: CSPC Pharmaceutical Group (Other OTC: CHJTF) and Moderna (NASDAQ: MRNA)
Macquarie Analyst forecast on CHJTF
Tony RenMacquarie
Macquarie
$0.64
Hold
-35.65%
Downside
Reiterated
05/30/25
Macquarie Sticks to Its Hold Rating for CSPC Pharmaceutical Group (CHJTF)
Morgan Stanley Analyst forecast on CHJTF
Yolanda HuMorgan Stanley
Morgan Stanley
$0.87
Buy
-12.49%
Downside
Reiterated
05/30/25
Morgan Stanley Remains a Buy on CSPC Pharmaceutical Group (CHJTF)
Citi Analyst forecast on CHJTF
Unknown AnalystCiti
Not Ranked
Citi
$1.15$1.17
Buy
18.40%
Upside
Reiterated
05/30/25
Citi Remains a Buy on CSPC Pharmaceutical Group (CHJTF)
CLSA
$1.59$1.53
Buy
54.43%
Upside
Reiterated
10/31/24
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Lowered to HK$12 at CLSACLSA analyst Zhijie Zhao lowered the price target on CSPC Pharmaceutical Group Ltd. (1093:HK) (OTC: CHJTF) to HK$12.00 (from HK$12.50) while maintaining a Outperform (2) rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on CHJTF
Rebecca LiangBernstein
Bernstein
$0.64
Hold
-35.65%
Downside
Reiterated
06/24/25
Bernstein Sticks to Its Hold Rating for CSPC Pharmaceutical Group (CHJTF)
Nomura
$1.02$1.3
Buy
31.52%
Upside
Reiterated
06/16/25
Nomura Sticks to Their Buy Rating for CSPC Pharmaceutical Group (CHJTF)
HSBC
$0.6$1.21
Buy
22.26%
Upside
Upgraded
06/05/25
Positive Report for CSPC Pharmaceutical Group (CHJTF) from HSBC
CMB International Securities Analyst forecast on CHJTF
Jill WuCMB International Securities
CMB International Securities
$0.73$1.28
Buy
29.72%
Upside
Reiterated
06/02/25
Analysts Are Bullish on These Healthcare Stocks: Kymera Therapeutics (KYMR), CSPC Pharmaceutical Group (CHJTF)
Jefferies Analyst forecast on CHJTF
Chu WangJefferies
Jefferies
$0.64
Sell
-35.65%
Downside
Downgraded
06/01/25
Analysts Conflicted on These Healthcare Names: CSPC Pharmaceutical Group (Other OTC: CHJTF) and Moderna (NASDAQ: MRNA)
Macquarie Analyst forecast on CHJTF
Tony RenMacquarie
Macquarie
$0.64
Hold
-35.65%
Downside
Reiterated
05/30/25
Macquarie Sticks to Its Hold Rating for CSPC Pharmaceutical Group (CHJTF)
Morgan Stanley Analyst forecast on CHJTF
Yolanda HuMorgan Stanley
Morgan Stanley
$0.87
Buy
-12.49%
Downside
Reiterated
05/30/25
Morgan Stanley Remains a Buy on CSPC Pharmaceutical Group (CHJTF)
Citi Analyst forecast on CHJTF
Unknown AnalystCiti
Not Ranked
Citi
$1.15$1.17
Buy
18.40%
Upside
Reiterated
05/30/25
Citi Remains a Buy on CSPC Pharmaceutical Group (CHJTF)
CLSA
$1.59$1.53
Buy
54.43%
Upside
Reiterated
10/31/24
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Lowered to HK$12 at CLSACLSA analyst Zhijie Zhao lowered the price target on CSPC Pharmaceutical Group Ltd. (1093:HK) (OTC: CHJTF) to HK$12.00 (from HK$12.50) while maintaining a Outperform (2) rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CSPC Pharmaceutical Group

1 Month
xxx
Success Rate
6/9 ratings generated profit
67%
Average Return
+3.82%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +3.82% per trade.
3 Months
xxx
Success Rate
7/9 ratings generated profit
78%
Average Return
+13.89%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 77.78% of your transactions generating a profit, with an average return of +13.89% per trade.
1 Year
Jill WuCMB International Securities
Success Rate
6/9 ratings generated profit
67%
Average Return
+19.86%
reiterated a buy rating last month
Copying Jill Wu's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +19.86% per trade.
2 Years
xxx
Success Rate
9/9 ratings generated profit
100%
Average Return
+41.86%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +41.86% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CHJTF Analyst Recommendation Trends

Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
3
3
4
5
7
Buy
0
0
0
0
0
Hold
2
2
1
2
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
5
5
7
11
In the current month, CHJTF has received 7 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. CHJTF average Analyst price target in the past 3 months is 0.97.
Each month's total comprises the sum of three months' worth of ratings.

CHJTF Financial Forecast

CHJTF Earnings Forecast

Next quarter’s earnings estimate for CHJTF is $0.02 with a range of $0.02 to $0.02. The previous quarter’s EPS was $0.02. CHJTF beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.09% of the time in the same period. In the last calendar year CHJTF has Outperformed its overall industry.
Next quarter’s earnings estimate for CHJTF is $0.02 with a range of $0.02 to $0.02. The previous quarter’s EPS was $0.02. CHJTF beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.09% of the time in the same period. In the last calendar year CHJTF has Outperformed its overall industry.

CHJTF Sales Forecast

Next quarter’s sales forecast for CHJTF is $1.07B with a range of $1.02B to $1.16B. The previous quarter’s sales results were ―. CHJTF beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.52% of the time in the same period. In the last calendar year CHJTF has Outperformed its overall industry.
Next quarter’s sales forecast for CHJTF is $1.07B with a range of $1.02B to $1.16B. The previous quarter’s sales results were ―. CHJTF beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.52% of the time in the same period. In the last calendar year CHJTF has Outperformed its overall industry.

CHJTF Stock Forecast FAQ

What is CHJTF’s average 12-month price target, according to analysts?
Based on analyst ratings, CSPC Pharmaceutical Group Limited’s 12-month average price target is 0.97.
    What is CHJTF’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CHJTF, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is CHJTF a Buy, Sell or Hold?
        CSPC Pharmaceutical Group Limited has a consensus rating of Moderate Buy which is based on 5 buy ratings, 2 hold ratings and 1 sell ratings.
          What is CSPC Pharmaceutical Group Limited’s price target?
          The average price target for CSPC Pharmaceutical Group Limited is 0.97. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $1.30 ,the lowest forecast is $0.64. The average price target represents -2.02% Decrease from the current price of $0.99.
            What do analysts say about CSPC Pharmaceutical Group Limited?
            CSPC Pharmaceutical Group Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 8 Wall Streets Analysts.
              How can I buy shares of CHJTF?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis